Excellence in Dermatology™
Excellence in Dermatologic Surgery™
Excellence in Medical Dermatology™
Excellence in Dermatopathology™

Return to program book search

Session Information

FRM F106 - Uses and Toxicities of Oncologic Drugs in Dermatology

Open admission to eligible categories, no tuition or ticket


Date: Monday, March 24

CME Credits: 2.00

Location: Room 205

Time: 10:00 AM - 12:00 PM

Director: Jennifer N. Choi, MD, FAAD

  • Sarah T. Arron, MD, PhD, FAAD
  • Jaehyuk Choi, MD, PhD
  • Mario E. Lacouture, MD, FAAD
  • Jennifer Y. Lin, MD, FAAD

Learning Objectives:
Following this course, the attendee should be able to:

  • Examine the use and toxicities of hedgehog pathway inhibitors in treatment of basal cell carcinoma.
  • Discuss the use and toxicities of BRAF inhibitors (including vemurafenib and dabrafenib) and MEK inhibitors (such as trametinib) in treatment of melanoma.
  • Discuss the use of systemic oncologic therapies for cutaneous diseases, such as EGFR inhibitors for cutaneous squamous cell carcinoma and imatinib for DFSP.

Novel targeted and biological therapies have become increasingly available in the treatment of cancer and other conditions. This is true also in the dermatologist's world. In this session, we will discuss recent advances in dermatologic therapies, including vismodegib for basal cell carcinoma, vemurafenib, dabrafenib, and trametinib for melanoma, immunotherapies including ipilimumab for melanoma, and the exploratory use of targeted agents, such as EGFR inhibitors for squamous cell carcinoma and imatinib for dermatofibrosarcoma protuberans and systemic mastocytosis. This session is directed to all general dermatologists, particularly those interested in the use of targeted and biological therapies.


Monday, March 24
10:00 AMIntroduction to Oncologic Drugs in Dermatology / Dr. Choi
10:05 AMHedgehog Pathway Inhibitors for Basal Cell Carcinoma / Dr. Arron
10:25 AMQuestion & Answer Period / Dr. Arron
10:28 AMUse and Toxicities of BRAF Inhibitors in the Treatment of Melanoma / Dr. Lin
10:48 AMQuestion & Answer Period / Dr. Lin
10:51 AMImmunotherapies for Skin Cancer / Dr. Choi
11:11 AMQuestion & Answer Period / Dr. Choi
11:14 AMUse of Oncologic Drugs for Skin Disease / Dr. Lacouture
11:34 AMQuestion & Answer Period / Dr. Lacouture
11:37 AMNon-Surgical Modalities in Melanoma Treatment / Dr. Choi
11:57 AMQuestion & Answer Session / Dr. Choi